{"id":"https://openalex.org/W9720570","doi":null,"title":"[Evaluation of antibiotic resistance patterns of Pseudomonas aeruginosa and Acinetobacter spp. strains isolated from intensive care patients between 2000-2002 and 2003-2006 periods in Dokuz Eylul University Hospital, Izmir].","display_name":"[Evaluation of antibiotic resistance patterns of Pseudomonas aeruginosa and Acinetobacter spp. strains isolated from intensive care patients between 2000-2002 and 2003-2006 periods in Dokuz Eylul University Hospital, Izmir].","publication_year":2009,"publication_date":"2009-04-01","ids":{"openalex":"https://openalex.org/W9720570","mag":"9720570","pmid":"https://pubmed.ncbi.nlm.nih.gov/19621603"},"language":"tr","primary_location":{"id":"pmid:19621603","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/19621603","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Mikrobiyoloji bulteni","raw_type":"Journal Article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5103002191","display_name":"Ay\u015fe Y\u00fcce","orcid":"https://orcid.org/0000-0003-2707-5654","observed_orcids":["https://orcid.org/0000-0003-2707-5654"]},"institutions":[{"id":"https://openalex.org/I193615760","display_name":"Dokuz Eyl\u00fcl University","ror":"https://ror.org/00dbd8b73","country_code":"TR","type":"education","lineage":["https://openalex.org/I193615760"]}],"countries":["TR"],"is_corresponding":false,"raw_author_name":"Ayse Y\u00fcce","raw_affiliation_strings":["Dokuz Eyl\u00fci Universitesi Tip Fak\u00fcltesi, Enfeksiyon Hastahliklan ve Klinik Mikrobiyoloji Anabilim Dali, Izmir. ayse.yuce@deu.edu.tr"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Dokuz Eyl\u00fci Universitesi Tip Fak\u00fcltesi, Enfeksiyon Hastahliklan ve Klinik Mikrobiyoloji Anabilim Dali, Izmir. ayse.yuce@deu.edu.tr","institution_ids":["https://openalex.org/I193615760"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5083993513","display_name":"Nur Yapar","orcid":"https://orcid.org/0000-0002-7759-5992","observed_orcids":["https://orcid.org/0000-0002-7759-5992"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Nur Yapar","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5032975959","display_name":"Oya \u00d6zlem Eren Kutsoylu","orcid":"https://orcid.org/0000-0003-3814-0474","observed_orcids":["https://orcid.org/0000-0003-3814-0474"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Oya Eren Kutsoylu","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.2128,"has_fulltext":false,"cited_by_count":9,"citation_normalized_percentile":{"value":0.57930214,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":97},"biblio":{"volume":"43","issue":"2","first_page":"195","last_page":"202"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10147","display_name":"Antibiotic Resistance in Bacteria","score":0.9897000193595886,"subfield":{"id":"https://openalex.org/subfields/2726","display_name":"Microbiology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10147","display_name":"Antibiotic Resistance in Bacteria","score":0.9897000193595886,"subfield":{"id":"https://openalex.org/subfields/2726","display_name":"Microbiology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10897","display_name":"Antibiotic Use and Resistance","score":0.004900000058114529,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11681","display_name":"Nosocomial Infections in ICU","score":0.0017999999690800905,"subfield":{"id":"https://openalex.org/subfields/2706","display_name":"Critical Care and Intensive Care Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/pseudomonas-aeruginosa","display_name":"Pseudomonas aeruginosa","score":0.9520000219345093},{"id":"https://openalex.org/keywords/acinetobacter","display_name":"Acinetobacter","score":0.9670000076293945},{"id":"https://openalex.org/keywords/antibiotic-resistance","display_name":"antibiotic resistance","score":0.8650000095367432},{"id":"https://openalex.org/keywords/multidrug-resistance","display_name":"multidrug resistance","score":0.824999988079071},{"id":"https://openalex.org/keywords/icu-acquired-infections","display_name":"intensive care unit infections","score":0.7710000276565552},{"id":"https://openalex.org/keywords/carbapenem-resistance","display_name":"carbapenem resistance","score":0.8999999761581421},{"id":"https://openalex.org/keywords/ceftazidime-resistance","display_name":"ceftazidime resistance","score":0.9359999895095825},{"id":"https://openalex.org/keywords/cefepime-resistance","display_name":"cefepime resistance","score":0.8289999961853027},{"id":"https://openalex.org/keywords/piperacillin-tazobactam","display_name":"piperacillin-tazobactam","score":0.8939999938011169},{"id":"https://openalex.org/keywords/antibiotic-stewardship","display_name":"antibiotic stewardship","score":0.6460000276565552},{"id":"https://openalex.org/keywords/antibiotic-use-guidelines","display_name":"antibiotic use guidelines","score":0.6909999847412109},{"id":"https://openalex.org/keywords/respiratory-tract-infections","display_name":"respiratory infections","score":0.5320000052452087},{"id":"https://openalex.org/keywords/nosocomial-infections","display_name":"nosocomial infections","score":0.3840000033378601}],"concepts":[{"id":"https://openalex.org/C2777050379","wikidata":"https://www.wikidata.org/wiki/Q2552927","display_name":"Cefepime","level":5,"score":0.7639138698577881},{"id":"https://openalex.org/C2776968632","wikidata":"https://www.wikidata.org/wiki/Q808845","display_name":"Ceftazidime","level":4,"score":0.6947061419487},{"id":"https://openalex.org/C2778193466","wikidata":"https://www.wikidata.org/wiki/Q423787","display_name":"Piperacillin","level":4,"score":0.682023823261261},{"id":"https://openalex.org/C2779631663","wikidata":"https://www.wikidata.org/wiki/Q425152","display_name":"Imipenem","level":4,"score":0.6517411470413208},{"id":"https://openalex.org/C2778523567","wikidata":"https://www.wikidata.org/wiki/Q310457","display_name":"Acinetobacter","level":3,"score":0.6157516837120056},{"id":"https://openalex.org/C89423630","wikidata":"https://www.wikidata.org/wiki/Q7193","display_name":"Microbiology","level":1,"score":0.6016077399253845},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.5911985039710999},{"id":"https://openalex.org/C2779375183","wikidata":"https://www.wikidata.org/wiki/Q421670","display_name":"Meropenem","level":4,"score":0.5575255751609802},{"id":"https://openalex.org/C2778719061","wikidata":"https://www.wikidata.org/wiki/Q417968","display_name":"Cefotaxime","level":3,"score":0.5522701740264893},{"id":"https://openalex.org/C94665300","wikidata":"https://www.wikidata.org/wiki/Q63391344","display_name":"Antibiotic resistance","level":3,"score":0.5439777374267578},{"id":"https://openalex.org/C2778512257","wikidata":"https://www.wikidata.org/wiki/Q256602","display_name":"Ciprofloxacin","level":3,"score":0.5229840278625488},{"id":"https://openalex.org/C2777637488","wikidata":"https://www.wikidata.org/wiki/Q31856","display_name":"Pseudomonas aeruginosa","level":3,"score":0.5032967925071716},{"id":"https://openalex.org/C2778266534","wikidata":"https://www.wikidata.org/wiki/Q423376","display_name":"Tazobactam","level":5,"score":0.5014419555664062},{"id":"https://openalex.org/C501593827","wikidata":"https://www.wikidata.org/wiki/Q12187","display_name":"Antibiotics","level":2,"score":0.4837767779827118},{"id":"https://openalex.org/C114851261","wikidata":"https://www.wikidata.org/wiki/Q12147416","display_name":"Drug resistance","level":2,"score":0.4290076494216919},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.40846478939056396},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.21912547945976257},{"id":"https://openalex.org/C523546767","wikidata":"https://www.wikidata.org/wiki/Q10876","display_name":"Bacteria","level":2,"score":0.08493083715438843},{"id":"https://openalex.org/C54355233","wikidata":"https://www.wikidata.org/wiki/Q7162","display_name":"Genetics","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000150","descriptor_name":"Acinetobacter","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":true},{"descriptor_ui":"D000151","descriptor_name":"Acinetobacter Infections","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D000151","descriptor_name":"Acinetobacter Infections","qualifier_ui":"Q000382","qualifier_name":"microbiology","is_major_topic":true},{"descriptor_ui":"D000900","descriptor_name":"Anti-Bacterial Agents","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D000900","descriptor_name":"Anti-Bacterial Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D001992","descriptor_name":"Bronchoalveolar Lavage Fluid","qualifier_ui":"Q000382","qualifier_name":"microbiology","is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007362","descriptor_name":"Intensive Care Units","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008826","descriptor_name":"Microbial Sensitivity Tests","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011550","descriptor_name":"Pseudomonas aeruginosa","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":true},{"descriptor_ui":"D011552","descriptor_name":"Pseudomonas Infections","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D011552","descriptor_name":"Pseudomonas Infections","qualifier_ui":"Q000382","qualifier_name":"microbiology","is_major_topic":true},{"descriptor_ui":"D014132","descriptor_name":"Trachea","qualifier_ui":"Q000382","qualifier_name":"microbiology","is_major_topic":false},{"descriptor_ui":"D014421","descriptor_name":"Turkey","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D024881","descriptor_name":"Drug Resistance, Bacterial","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true}],"locations_count":2,"locations":[{"id":"pmid:19621603","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/19621603","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Mikrobiyoloji bulteni","raw_type":"Journal Article"},{"id":"mag:9720570","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/19621603","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"PubMed","raw_type":null}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.9763000011444092,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2335944814","https://openalex.org/W2561276799","https://openalex.org/W2414402818","https://openalex.org/W7098459396","https://openalex.org/W2357830186","https://openalex.org/W2380496848","https://openalex.org/W2340852664","https://openalex.org/W2374240875","https://openalex.org/W2318808971","https://openalex.org/W2319027584"],"abstract_inverted_index":{"Multi-drug":[0],"resistant":[1],"Pseudomonas":[2],"aeruginosa":[3,34,91,104,160],"and":[4,35,65,87,92,101,105,143,173,184,227],"Acinetobacter":[5,36,94,107,187],"spp.":[6,37,95,108],"infections":[7],"are":[8],"becoming":[9],"an":[10],"important":[11],"problem":[12],"all":[13],"throughout":[14],"the":[15,28,39,52,75,77,117,120,133,203,210,221,241,249],"world":[16],"as":[17,19],"well":[18],"in":[20,38,83,193,202,217],"our":[21,218],"country.":[22],"In":[23,209],"this":[24,194,244],"study,":[25],"we":[26],"evaluated":[27,82],"drug":[29],"resistance":[30,79,157,161,205,235],"rates":[31,80,178,206,236],"of":[32,43,132,243,252],"P.":[33,90,103,159],"intensive":[40],"care":[41],"units":[42],"Dokuz":[44],"Eyl\u00fcl":[45],"University":[46],"Hospital,":[47],"Izmir,":[48],"Turkey.":[49],"Since":[50],"by":[51,62,74,147],"year":[53,211],"2003,":[54],"antibiotic":[55,71,78,156,204,234,245],"consumption":[56],"is":[57],"started":[58],"to":[59,70,116,240,248],"be":[60,238],"controlled":[61],"infectious":[63,225],"disease":[64,226],"clinical":[66,228],"microbiology":[67,229],"specialists":[68,230],"according":[69],"policies":[72],"ruled":[73],"government,":[76],"were":[81,114,122,145,179,199],"two":[84],"periods":[85],"(2000-2002":[86],"2003-2006).":[88],"Seventynine":[89],"89":[93],"isolated":[96,109],"during":[97,110],"January":[98],"2000-December":[99],"2002":[100],"66":[102],"48":[106],"january":[111],"2003-December":[112],"2006":[113],"included":[115],"study.":[118],"All":[119],"isolates":[121,134],"from":[123],"deep":[124],"tracheal":[125],"aspirate":[126],"or":[127],"bronchoalveolar":[128],"lavage":[129],"specimens.":[130],"Susceptibilities":[131],"against":[135],"meropenem,":[136],"imipenem,":[137],"piperacillin-tazobactam,":[138],"cefepime,":[139],"cefotaxime,":[140],"ceftazidime,":[141],"tobramycine":[142],"ciprofloxacin":[144],"determined":[146],"E-test":[148],"(AB":[149],"Biodisk,":[150],"Sweden).":[151],"The":[152,190,232],"results":[153],"indicated":[154,196],"high":[155,233],"rates.":[158],"rate":[162],"for":[163,186],"ceftazidime":[164],"was":[165],"84%,":[166],"cefepime":[167],"83%,":[168],"carbapenemes":[169],"73%,":[170],"ciprofloxacine":[171],"87%":[172],"piperacillin-tazobactam":[174],"88%":[175],"while":[176],"these":[177],"98%,":[180],"95.6%,":[181],"87%,":[182],"100%":[183,185],"spp.,":[188],"respectively.":[189],"data":[191],"obtained":[192],"study":[195],"that":[197],"there":[198],"no":[200],"decrease":[201],"after":[207],"2003.":[208],"2005,":[212],"\"Antibiotic":[213],"use":[214,251],"guideline\"":[215],"established":[216],"hospital":[219],"let":[220],"antibiotics":[222],"used":[223],"without":[224],"consultation.":[231],"may":[237],"attributed":[239],"application":[242],"guideline":[246],"leading":[247],"uncontrolled":[250],"antibiotics.":[253]},"counts_by_year":[{"year":2022,"cited_by_count":1},{"year":2018,"cited_by_count":1},{"year":2017,"cited_by_count":2},{"year":2015,"cited_by_count":1},{"year":2014,"cited_by_count":3},{"year":2012,"cited_by_count":1}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2016-06-24T00:00:00"}